For 40 years, as a guide for physicians and the general public, the US Preventive Services Task Force (USPSTF) has reviewed the scientific evidence and issued critical recommendations on preventive health measures, including screening for cancers of the cervix, colorectum, and breast.1 In 2010, Congress passed the Patient Protection and Affordable Care Act (ACA), which included a provision (Section 2713) that preventive health recommendations issued by the USPSTF and assigned an A or B rating (the highest ratings, indicating the strongest evidence in support) must be covered by most private health insurers without cost-sharing.2 The same coverage mandate applied to vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP) and preventive health measures recommended by the Health Resources and Services Administration (HRSA). The ACA provided that the USPSTF and its recommendations 鈥溾�hall be independent and, to the extent practicable, not subject to political pressure.鈥�3